Pedialyte or Gatorade for Viral Gastroenteritis in Adults: a Randomized, Controlled Trial
|ClinicalTrials.gov Identifier: NCT00257374|
Recruitment Status : Completed
First Posted : November 22, 2005
Last Update Posted : January 9, 2014
Background: Pedialyte and Gatorade are advocated for the treatment of dehydration in viral gastroenteritis, but there is limited evidence to support their use.
Objective: To examine the efficacy, safety and palatability of Pedialyte, Gatorade, and a New Oral Rehydration Solution (NS).
Design: Randomized double blind. Setting: Inpatient, community hospital. Patients/Interventions: 75 consecutive adult patients (m/f=44/33) admitted with viral gastroenteritis were randomized to receive Gatorade, Pedialyte or NS for 48 hours. A yogurt/rice diet was allowed ad libitum.
Measurements: Stool and urine output, electrolytes, fluid intake, body weight, hematocrit and palatability of solutions.
Limitations: Smaller sample size and higher drop out (20%).
|Condition or disease||Intervention/treatment|
|Gastroenteritis||Drug: Gatorade, Pedialyte and New Solution|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00257374
|Dept. of Gastroenterology & Infectious Disease, Osmania Medical College|
|Hyderabad, India, 500012|
|Principal Investigator:||Satish SC Rao, MD,PhD, FRCP(LON)||University of Iowa|